loader
Please Wait
Applying Filters...

Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about IRON SUBSULFATE, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    IRON SUBSULFATE

    APIs // Active Pharmaceutical Ingredients

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    PharmaCompass

    Bora Pharmaceuticals- Making success more certain.

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    2D Structure
    1. Also known as: 1310-45-8, Ferric subsulfate solution, Basic ferric sulfate, Iron hydroxide sulfate (fe4(oh)2(so4)5), Iron(3+);dihydroxide;pentasulfate, 3qj8ws6v8h
    Molecular Formula
    Fe4H2O22S5
    Molecular Weight
    737.7  g/mol
    InChI Key
    GDPKWKCLDUOTMP-UHFFFAOYSA-B
    FDA UNII
    3QJ8WS6V8H
    Ferric subsulfate is a stypic or hemostatic agent that causes agglutination of surface proteins resulting in local hemostasis. It has the chemical formula Fe4(OH)2(SO4)5. It is used after superficial skin biopsies.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    iron(3+);dihydroxide;pentasulfate
    2.1.2 InChI
    InChI=1S/4Fe.5H2O4S.2H2O/c;;;;5*1-5(2,3)4;;/h;;;;5*(H2,1,2,3,4);2*1H2/q4*+3;;;;;;;/p-12
    2.1.3 InChI Key
    GDPKWKCLDUOTMP-UHFFFAOYSA-B
    2.1.4 Canonical SMILES
    [OH-].[OH-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Fe+3].[Fe+3].[Fe+3].[Fe+3]
    2.2 Other Identifiers
    2.2.1 UNII
    3QJ8WS6V8H
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Ferric Subsulfate Solution

    2. Monsel's Solution

    2.3.2 Depositor-Supplied Synonyms

    1. 1310-45-8

    2. Ferric Subsulfate Solution

    3. Basic Ferric Sulfate

    4. Iron Hydroxide Sulfate (fe4(oh)2(so4)5)

    5. Iron(3+);dihydroxide;pentasulfate

    6. 3qj8ws6v8h

    7. Monsel's Solution

    8. Iron Dihydroxide Pentakis(sulphate)

    9. Einecs 215-179-2

    10. Unii-3qj8ws6v8h

    11. Ferric Subsulfate [usp:nf]

    12. Iron Hydroxide Sulfate

    13. Iron Subsulfate

    14. Ferric Subsulphate

    15. Ferric Subsulfate (usp)

    16. Basic Ferric Sulfate Solution

    17. Monsel's Solution [mi]

    18. Dtxsid30893846

    19. Ferric Subsulfate [vandf]

    20. Ferric Subsulphate Solution

    21. Ferric Subsulfate [who-dd]

    22. Ferric Subsulfate Decahydrate

    23. Basic Ferric Sulphate Solution

    24. Akos015910508

    25. Ferric Subsulfate [usp Impurity]

    26. Iron Dihydroxide Pentakis Sulfate

    27. Iron(iii) Dihydroxide Pentakis(sulfate)

    28. Iron Dihydroxide Pentakis Sulphate

    29. Ft-0717042

    30. D08921

    31. Iron Hydroxide Sulphate (fe4(oh)2(so4)5)

    32. Q5445335

    2.4 Create Date
    2005-08-08
    3 Chemical and Physical Properties
    Molecular Weight 737.7 g/mol
    Molecular Formula Fe4H2O22S5
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count22
    Rotatable Bond Count0
    Exact Mass737.50387 g/mol
    Monoisotopic Mass737.50387 g/mol
    Topological Polar Surface Area445 Ų
    Heavy Atom Count31
    Formal Charge0
    Complexity62.2
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count11
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Hemostatics

    Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. (See all compounds classified as Hemostatics.)

    4.2 FDA Pharmacological Classification
    4.2.1 Pharmacological Classes
    Parenteral Iron Replacement [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Iron [CS]
    Post Enquiry
    POST ENQUIRY